ArticleCancer medicine2026
Perioperative Changes in Peripheral Natural Killer Cell Activity and Their Association With Clinicopathological Features in Breast Cancer: A Single-Center Cohort Study.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to evaluate perioperative changes in peripheral blood natural killer (NK) cell activity (ACT) in patients with breast cancer and to investigate the relationship between NK activity and clinicopathological characteristics.
methodsA single-center retrospective cohort including 34 female patients with available preoperative and postoperative NK activity measurements was analyzed. Clinical and pathological variables were obtained from medical records. NK activity levels at two time points were compared, and the association between NK activity difference and age, tumor size, TNM stage, hormone receptor status, HER2 expression, Ki-67 index, number of metastatic lymph nodes, and serum tumor markers was assessed. NK cell activity was assessed using the NK Vue assay (ATgen, Seongnam, Republic of Korea), a whole-blood stimulation assay based on interferon-gamma (IFN-γ) release.
resultsPostoperative NK activity significantly increased compared with preoperative levels (p = 0.041). However, the change in NK activity was not significantly associated with tumor stage, lymph node involvement, tumor size, proliferation index, receptor status, HER2 expression, metastatic lymph node count, or serum tumor markers (all p > 0.05). The overall metastatic rate during follow-up was low.
conclusionSurgical treatment appears to exert a favorable effect on peripheral NK cell activity in breast cancer. The absence of a clear correlation between NK activity changes and clinicopathological parameters suggests that NK responses may reflect an individualized immunologic capacity rather than tumor-specific features. Larger prospective studies integrating NK cell subsets and functional phenotyping are required to better define the prognostic and predictive value of NK cell activity in breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.